Charles Winter
Chief Tech/Sci/R&D Officer at JANUX THERAPEUTICS, INC.
Net worth: - $ as of 2024-04-29
Profile
Charles Winter is currently the Chief Technical Officer at Janux Therapeutics, Inc. Prior to this, he worked as the Director of Biologics Development at Gilead Sciences, Inc. from 2011 to 2015, and as the Vice President of Manufacturing & Technology at Eden Biologics, Inc. from 2015 to 2016.
Winter received his undergraduate degree from the University of Wisconsin.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
JANUX THERAPEUTICS, INC.
-.--% | 2024-01-01 | 0 ( -.--% ) | - $ | 2024-04-29 |
Charles Winter active positions
| Companies | Position | Start |
|---|---|---|
| JANUX THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2020-12-31 |
Former positions of Charles Winter
| Companies | Position | End |
|---|---|---|
| JHL BIOTECH, INC. | Chief Tech/Sci/R&D Officer | 2016-07-31 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 2015-05-31 |
Training of Charles Winter
| University of Wisconsin | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| JANUX THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Eden Biologics, Inc.
 Eden Biologics, Inc. Pharmaceuticals: MajorHealth Technology Eden Biologics, Inc. is engaged in the manufacture and sale of bio-pharmaceuticals products. It offers cell line cloning, antibody cloning, monoclonal antibody, cell line development, master and working cell banks, cell culture process development, purification process development, formulation development, and analytical assays. The company was founded on June 14, 2012 and is headquartered in Zhupei, Taiwan. | Health Technology |
- Stock Market
- Insiders
- Charles Winter
